Immune factors such as cytokines, chemokines, and growth factors are known to play important roles in the preimplantation interactions and communication between the blastocyst and receptive endometrium. This crucial dialog occurs during the stages when the blastocyst is in the uterine cavity immediately preceding implantation and the establishment of pregnancy. Human preimplantation processes are difficult to study due to restrictions on tissue availability. This review focuses on the expression and role of immune factors in human blastocyst-endometrial dialog during the very early stages of implantation. It highlights the importance of immune regulators and the need to develop new models to study human implantation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/aji.12038 | DOI Listing |
Hum Reprod Update
September 2023
Juno Genetics, Rome, Italy.
Background: A normal chromosomal constitution defined through PGT-A assessing all chromosomes on trophectoderm (TE) biopsies represents the strongest predictor of embryo implantation. Yet, its positive predictive value is not higher than 50-60%. This gap of knowledge on the causes of euploid blastocysts' reproductive failure is known as 'the black box of implantation'.
View Article and Find Full Text PDFInt J Environ Res Public Health
June 2021
Gynecology Division, Department of Medical and Surgical Sciences and Translational Medicine, Sant'Andrea University Hospital, Sapienza University of Rome, Via di Grottarossa 1035, 00189 Rome, Italy.
Several available studies have already analyzed the systemic effects of endocrine-disrupting chemicals (EDCs) on fertile woman and neonatal outcomes, but little is still known in humans about the precise mechanisms of interference of these compounds with the endometrial receptivity. There is consistent evidence that continuous and prolonged exposure to EDCs is a risk factor for reduced fertility and fecundity in women. Preliminary studies on mammalian models provide robust evidence about this issue and could help gynecologists worldwide to prevent long term injury caused by EDCs on human fertility.
View Article and Find Full Text PDFBMJ Open
December 2019
The Fertility Clinic, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Introduction: Despite the high number of frozen embryo transfer (FET) cycles being conducted (190 000 cycles/year) in Europe, the timing of blastocyst transfer and the use of luteal phase progesterone support in modified natural cycle FET (mNC-FET) in assisted reproductive technologies are controversial. In mNC-FET, the timing of blastocyst warming and transfer is determined according to the time of implantation in a natural cycle, aiming to reach blastocyst endometrial synchronicity. However, the optimal day of blastocyst transfer following ovulation trigger is not determined.
View Article and Find Full Text PDFFertil Steril
September 2016
Department of Obstetrics and Gynecology, Chinese PLA General Hospital and Chinese PLA Medical School, Beijing, People's Republic of China. Electronic address:
Objective: To determine whether placenta-specific 8 (PLAC8) is expressed in human oocytes and embryos, and whether PLAC8 interferes with the implantation process.
Design: Experimental.
Setting: Academic medical assisted reproduction center.
Fertil Steril
January 2016
GENERA, Centre for Reproductive Medicine, Clinica Valle Giulia, Rome, Italy; GENETYX, Molecular Genetics Laboratory, Vicenza, Italy.
Objective: To assess whether extracellular microRNAs (miRNAs) can be accurately profiled from spent blastocyst culture media (SBM) and used as embryonic biomarkers.
Design: Prospective cohort study.
Setting: Private and academic in vitro fertilization centers.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!